Monocyte Chemoattractant Protein-1–Deficiency Results in Altered Blood–Brain Barrier Breakdown After Experimental Stroke
- 1 September 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 44 (9) , 2536-2544
Abstract
Background and Purpose—: Stroke-induced blood–brain barrier (BBB)-disruption can contribute to further progression of cerebral damage. There is rising evidence for a strong involvement of chemokines in postischemic BBB-breakdown. In a previous study, we showed that monocyte chemoattractant protein-1 (MCP-1)–deficiency results in a markedly reduced inflammatory reaction with decreased levels of interleukin-6, interleukin-1β, and granulocyte colony-stimulating factor after experimental stroke. With MCP-1 as one of the key players in stroke-induced inflammation, in this study, we investigated the influence of MCP-1 on poststroke BBB-disruption as well as transcription/translation of BBB-related genes/proteins after cerebral ischemia. Methods—: Sixteen wild-type and 16 MCP-1 −/− mice were subjected to 30 minutes of middle cerebral artery occlusion. By injecting high molecular-tracer, we compared the degree of BBB-disruption after middle cerebral artery occlusion. Real-time polymerase chain reactions and Western blot technique were used to compare tight-junction gene expression, protein secretion, and BBB-leakage. Results—: Here, we report that MCP-1–deficiency results in a reduced BBB-leakage and a diminished expression of BBB-related genes occludin, zonula occludens-1, and zonula occludens-2. Real-time polymerase chain reactions and Western blot analysis revealed elevated claudin-5–levels in MCP-1 −/− animals. MCP-1–deficiency resulted in reduced infarct sizes and an increased vascular accumulation of fluorescein-isothiocyanate-albumin. Conclusions—: The results of the study provide further insights into the molecular mechanisms of BBB-opening and may help to better understand the mechanisms of infarct development after cerebral ischemia.Keywords
This publication has 27 references indexed in Scilit:
- Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood–Brain Barrier Damage in Early Ischemic Stroke StageThe Journal of Neuroscience, 2012
- Monocyte Chemoattractant Protein-1-Deficiency Impairs the Expression of IL-6, IL-1β and G-CSF after Transient Focal Ischemia in MicePLOS ONE, 2011
- Truncation of monocyte chemoattractant protein 1 by plasmin promotes blood–brain barrier disruptionJournal of Cell Science, 2011
- Severe Blood–Brain Barrier Disruption and Surrounding Tissue InjuryStroke, 2009
- Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial CellsJournal of Biological Chemistry, 2009
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Hypertensive encephalopathy and the blood-brain barrier: is δPKC a gatekeeper?Journal of Clinical Investigation, 2008
- Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillariesBiochemical and Biophysical Research Communications, 2006
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001